Role Of Dna And Rna In Drug Development
DOI:
https://doi.org/10.64882/ijrt.v14.i2.1281Keywords:
DNA, RNA, Drug Development, Gene Therapy, Personalized Medicine, RNA Therapeutics.Abstract
The DNA and RNA are indispensable parts of the contemporary drug development process due to their contribution to personalized medication, gene therapy, vaccines, and targeted drugs. The objective of the current research is to explore the awareness and use as well as the problems related to DNA and RNA-based drugs among those who are involved in the field of pharmaceutical or biomedical sciences. The descriptive cross-sectional study has been carried out with a sample of 200 respondents who were chosen purposefully. According to the results of the study, two major categories of participants were Pharmaceutical Researchers and Biotechnology Scientists (29% and 23% respectively). High awareness level concerning nucleic acid technologies was seen, as the number of highly aware individuals reached 48%, while the number of moderately aware ones was 35.5%. Personalized Medicine ranked first among all applications of interest, as 30.5% of participants found it most important. Other top applications include Gene Therapy (24.5%) and Vaccines Creation (21%). The study uncovered major problems in the field, such as High Costs (33.5%), Difficulties with Delivery System (25.5%), as well as Safety and Ethical Issues (19.5%). Overall, the results point out to the huge potential of DNA and RNA applications for pharmaceutical research. Still, certain barriers must be overcome to achieve success.
References
Cullis, P. R., & Felgner, P. L. (2024). The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nature Reviews Drug Discovery, 23(9), 709-722.
Desai, D., Kantliwala, S. V., Vybhavi, J., Ravi, R., Patel, H., Patel, J., & RAVI, R. (2024). Review of AlphaFold 3: transformative advances in drug design and therapeutics. Cureus, 16(7).
Dhuri, K., Bechtold, C., Quijano, E., Pham, H., Gupta, A., Vikram, A., & Bahal, R. (2020). Antisense oligonucleotides: an emerging area in drug discovery and development. Journal of clinical medicine, 9(6), 2004.
Egli, M., & Manoharan, M. (2023). Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic acids research, 51(6), 2529-2573.
Kato, D. (2024). Exploring the dynamic world of DNA and RNA: from structure to function and beyond. INOSR Appl Sci, 12, 57-62.
Michalak, E. M., Burr, M. L., Bannister, A. J., & Dawson, M. A. (2019). The roles of DNA, RNA and histone methylation in ageing and cancer. Nature reviews Molecular cell biology, 20(10), 573-589.
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022). Drug delivery systems for RNA therapeutics. Nature Reviews Genetics, 23(5), 265-280.
Qureshi, R., Irfan, M., Gondal, T. M., Khan, S., Wu, J., Hadi, M. U., ... & Alam, T. (2023). AI in drug discovery and its clinical relevance. Heliyon, 9(7).
Shen, X., & Corey, D. R. (2018). Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic acids research, 46(4), 1584-1600.
Spiegel, J., Adhikari, S., & Balasubramanian, S. (2020). The structure and function of DNA G-quadruplexes. Trends in chemistry, 2(2), 123-136.
Tani, H. (2024). Recent advances and prospects in RNA drug development. International journal of molecular sciences, 25(22), 12284.
Van de Sande, B., Lee, J. S., Mutasa-Gottgens, E., Naughton, B., Bacon, W., Manning, J., ... & Ferran, E. (2023). Applications of single-cell RNA sequencing in drug discovery and development. Nature reviews Drug discovery, 22(6), 496-520.
Varshney, D., Spiegel, J., Zyner, K., Tannahill, D., & Balasubramanian, S. (2020). The regulation and functions of DNA and RNA G-quadruplexes. Nature reviews Molecular cell biology, 21(8), 459-474.
Warner, K. D., Hajdin, C. E., & Weeks, K. M. (2018). Principles for targeting RNA with drug-like small molecules. Nature reviews Drug discovery, 17(8), 547-558.
Zhao, L. Y., Song, J., Liu, Y., Song, C. X., & Yi, C. (2020). Mapping the epigenetic modifications of DNA and RNA. Protein & cell, 11(11), 792-808.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
